HealthcareServices

Global Chronic Pain Market Performance Report: Global Trends 2026–2030

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the chronic pain market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Chronic Pain Market reach by 2030 starting from 2026 levels?

The chronic pain market has demonstrated robust expansion over recent years. Its size is anticipated to rise from $84.66 billion in 2025 to $91.67 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. The factors contributing to this growth in the past include the increasing prevalence of chronic diseases, a rising incidence of neuropathic and musculoskeletal pain, broader availability of pain medications, enhanced clinical recognition of chronic pain, and the expansion of pain clinics.

The chronic pain market is set to experience significant growth in the coming years, with its size projected to reach $127.4 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This anticipated expansion is fueled by factors such as an escalating demand for personalized pain treatments, the increasing adoption of bioelectronic devices, the wider availability of telehealth-based pain care, a heightened focus on opioid alternatives, and amplified investment in pain research. Dominant trends during this forecast period include the increasing integration of multidisciplinary pain care models, a rise in the utilization of neuromodulation devices, a growing preference for non-opioid drug therapies, the expansion of home-based pain management solutions, and enhanced incorporation of digital health platforms.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11970&type=smp

Which Drivers Are Influencing Long-Term Growth In The Chronic Pain Market?

The widespread presence of chronic pain patients is anticipated to drive the expansion of the chronic pain market. These patients are individuals who experience persistent or long-lasting pain extending beyond the normal healing process or enduring for an extended period, typically over three months. The significant number of chronic pain patients propels the chronic pain market’s growth, as the increasing demand for effective pain management solutions, including pharmaceuticals and medical devices, creates opportunities for innovation and development within the industry. For instance, in June 2024, information from the Australian Institute of Health and Welfare, an Australia-based government agency, revealed that an estimated 4.0 million Australians (16% of the population) were affected by back problems in 2022. By 2023, back problems became the third leading cause of disease burden, contributing to 4.3% of the country’s total disease burden. Additionally, in February 2024, another report released by the Institute for Health Metrics and Evaluation, a US-based national and international public health agency and research institute, indicated that projected global cases of neck pain are expected to reach 269 million by 2050 (ranging from 219 to 322 million). Therefore, the prevalence of chronic pain patients is indeed a primary driver for the growth of the chronic pain market.

Which Segments Are Driving Activity In The Chronic Pain Market?

The chronic pain market covered in this report is segmented –

1) By Product: Drug, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By End User: Hospitals, Clinics, Research Organization

Subsegments:

1) By Drug: Non-Opioid Analgesics, Opioids, Antidepressants, Anticonvulsants, Topical Analgesics, Corticosteroids

2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units, Spinal Cord Stimulators, Intrathecal Drug Delivery Systems, Heat And Cold Therapy Devices, Bioelectronic Devices

Which Trends Are Influencing The Development Of The Chronic Pain Market?

Companies active in the chronic pain sector are increasingly engaging in strategic partnerships to introduce shared savings initiatives aimed at managing chronic pain. Such collaborations involve organizations utilizing one another’s capabilities and assets to secure reciprocal advantages and achieve success. A relevant instance occurred in August 2023, when MOBE, a digital health innovator from the US, formed an alliance with Override Health, another US-based healthcare firm. This alliance is designed to tackle chronic pain management through a shared savings model, integrating their distinct areas of expertise. As a health outcomes provider, MOBE applies healthcare data analytics to guide its personalized, one-on-one health coaching and medication management framework. Conversely, Override offers a comprehensive program encompassing virtual interdisciplinary care, coaching focused on neuroplasticity, and peer assistance, assisting individuals with chronic pain in navigating fragmented care systems.

Which Leading Companies Dominate The Chronic Pain Market Share?

Major companies operating in the chronic pain market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, Dickinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Chronic Pain Market?

North America was the largest region in the chronic pain market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Chronic Pain Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11970&type=smp

Browse Through More Reports Similar to the Global Chronic Pain Market 2026, By The Business Research Company

Pain Management Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Chronic Lower Back Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report

Neuropathic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795